Matzinger et al. - 2009 - Quality assurance in the 22991 EORTC ROG trial in localized prostate cancer dummy run and individual case review. - Radiother Oncol.pdf
scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.
Bibliography
Pettersen M.N., Aird E., and Olsen D.R. Quality assurance of dosimetry and the impact on sample size in randomized clinical trials. Radiother Oncol 86 (2008) 195-199
Bentzen S.M., Bernier J., Davis J.B., et al. Clinical impact of dosimetry quality assurance programmes assessed by radiobiological modelling of data from the thermoluminescent dosimetry study of the European Organization for Research and Treatment of Cancer. Eur J Cancer 36 (2000) 615-620
Poortmans P.M., Venselaar J.L., Struikmans H., et al. The potential impact of treatment variations on the results of radiotherapy of the internal mammary lymph node chain: a quality-assurance report on the dummy run of EORTC Phase III randomized trial 22922/10925 in Stage I-III breast cancer (1). Int J Radiat Oncol Biol Phys 49 (2001) 1399-1408
Poortmans P.M., Davis J.B., Ataman F., Bernier J., and Horiot J.C. The quality assurance programme of the Radiotherapy Group of the European Organisation for Research and Treatment of Cancer: past, present and future. Eur J Surg Oncol 31 (2005) 667-674
Budiharto T., Musat E., Poortmans P., et al. Profile of European radiotherapy departments contributing to the EORTC Radiation Oncology Group (ROG) in the 21st century. Radiother Oncol 88 (2008) 403-410
Ataman F., Poortmans P., Davis J.B., et al. High conformality radiotherapy in Europe: thirty-one centres participating in the quality assurance programme of the EORTC prostate trial 22991. Eur J Cancer 40 (2004) 2411-2416
Poortmans P.M., Ataman F., Davis J.B., et al. Quality assurance in the EORTC phase III randomised 'boost vs. no boost' trial for breast conserving therapy: comparison of the results of two individual case reviews performed early and late during the accrual period. Radiother Oncol 76 (2005) 278-284
Jeanneret-Sozzi W., Moeckli R., Valley J.F., et al. The reasons for discrepancies in target volume delineation: a SASRO study on head-and-neck and prostate cancers. Strahlenther Onkol 182 (2006) 450-457
Kouloulias V.E., Giraud J.Y., Davis B.J., Dusserre A., Zurlo A., and Bolla M. Quality assurance of the 22961 EORTC trial. A phase III study of the optimal combination of hormonal adjuvant treatment by LHRH analogue and radiation therapy for the management of locally advanced prostate cancer: the dummy run. Radiother Oncol 73 (2004) 11-20
Seddon B., Bidmead M., Wilson J., Khoo V., and Dearnaley D. Target volume definition in conformal radiotherapy for prostate cancer: quality assurance in the MRC RT-01 trial*1. Radiother Oncol 56 (2000) 73-83
Liu Y.M., Ling S., Langen K.M., et al. Prostate movement during simulation resulting from retrograde urethrogram compared with "natural" prostate movement. Int J Radiat Oncol Biol Phys 60 (2004) 470-475
Debois M., Oyen R., Maes F., et al. The contribution of magnetic resonance imaging to the three-dimensional treatment planning of localized prostate cancer. Int J Radiat Oncol Biol Phys 45 (1999) 857-865
Boehmer D., Maingon P., Poortmans P., et al. Guidelines for primary radiotherapy of patients with prostate cancer. Radiother Oncol 79 (2006) 259-269
Carroll P.R., Coakley F.V., and Kurhanewicz J. Magnetic resonance imaging and spectroscopy of prostate cancer. Rev Urol 8 Suppl 1 (2006) S4-S10
Parker C.C., Damyanovich A., Haycocks T., Haider M., Bayley A., and Catton C.N. Magnetic resonance imaging in the radiation treatment planning of localized prostate cancer using intra-prostatic fiducial markers for computed tomography co-registration. Radiother Oncol 66 (2003) 217-224
Villeirs G.M., Van Vaerenbergh K., Vakaet L., et al. Interobserver delineation variation using CT versus combined CT + MRI in intensity-modulated radiotherapy for prostate cancer. Strahlenther Onkol 181 (2005) 424-430
van der Laan H.P., van den Bergh A., Schilstra C., Vlasman R., Meertens H., and Langendijk J.A. Grading-system-dependent volume effects for late radiation-induced rectal toxicity after curative radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 70 (2008) 1138-1145
Storey M.R., Pollack A., Zagars G., Smith L., Antolak J., and Rosen I. Complications from radiotherapy dose escalation in prostate cancer: preliminary results of a randomized trial. Int J Radiat Oncol Biol Phys 48 (2000) 635-642
Jackson A., Skwarchuk M.W., Zelefsky M.J., et al. Late rectal bleeding after conformal radiotherapy of prostate cancer. II. Volume effects and dose-volume histograms. Int J Radiat Oncol Biol Phys 49 (2001) 685-698
Vargas C., Yan D., Kestin L.L., et al. Phase II dose escalation study of image-guided adaptive radiotherapy for prostate cancer: Use of dose-volume constraints to achieve rectal isotoxicity. Int J Radiat Oncol Biol Phys 63 (2005) 141-149
Peeters S.T., Lebesque J.V., Heemsbergen W.D., et al. Localized volume effects for late rectal and anal toxicity after radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 64 (2006) 1151-1161
Chan L.W., Xia P., Gottschalk A.R., et al. Proposed rectal dose constraints for patients undergoing definitive whole pelvic radiotherapy for clinically localized prostate cancer. Int J Radiat Oncol Biol Phys 72 (2008) 69-77
Poortmans P., Bossi A., Vandeputte K., et al. Guidelines for target volume definition in post-operative radiotherapy for prostate cancer, on behalf of the EORTC Radiation Oncology Group. Radiother Oncol 84 (2007) 121-127
Similar publications
Sorry the service is unavailable at the moment. Please try again later.
This website uses cookies to improve user experience. Read more
Save & Close
Accept all
Decline all
Show detailsHide details
Cookie declaration
About cookies
Strictly necessary
Performance
Strictly necessary cookies allow core website functionality such as user login and account management. The website cannot be used properly without strictly necessary cookies.
This cookie is used by Cookie-Script.com service to remember visitor cookie consent preferences. It is necessary for Cookie-Script.com cookie banner to work properly.
Performance cookies are used to see how visitors use the website, eg. analytics cookies. Those cookies cannot be used to directly identify a certain visitor.
Used to store the attribution information, the referrer initially used to visit the website
Cookies are small text files that are placed on your computer by websites that you visit. Websites use cookies to help users navigate efficiently and perform certain functions. Cookies that are required for the website to operate properly are allowed to be set without your permission. All other cookies need to be approved before they can be set in the browser.
You can change your consent to cookie usage at any time on our Privacy Policy page.